EQUITY-METHOD INVESTMENTS (Tables)

9 Months Ended

Sep. 30, 2019

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Condensed Financial Information of Equity Method Investments

The following presents condensed financial information as of September 30, 2019 and December 31, 2018 and for the three and nine months ended September 30, 2019 and 2018 (in thousands).



Consolidated statements of comprehensive income (loss) data:
	Three Months Ended September 30,				Nine Months Ended September 30,
	2019		2018		2019		2018
Net revenue	$	5,814	$	5,572	$	15,210	$	15,728
Cost of revenue	4,083		3,853		10,882		11,132
Gross profit	1,731		1,719		4,328		4,596
Net income	670		402		1,177		1,225
Equity in net income	335		201		588		612

Consolidated balance sheet data:
					As of
					September 30, 2019		December 31, 2018
Current assets					$	6,358	$	5,666
Noncurrent assets					4,072		3,403
Current liabilities					572		119
Noncurrent liabilities					740		8

The following presents condensed financial information as of September 30, 2019 and December 31, 2018 and for the three and nine months ended September 30, 2019 and 2018 (in thousands).



Consolidated statements of comprehensive income (loss) data:
	Three Months Ended September 30,				Nine Months Ended September 30,
	2019		2018		2019		2018
Net revenue	$	9,638	$	7,659	$	28,701	$	22,055
Cost of revenue	7,473		5,718		21,989		16,943
Gross profit	2,165		1,941		6,712		5,112
Net income	982		199		2,859		88
Equity in net income	491		100		1,430		44

Consolidated balance sheet data:
					As of
					September 30, 2019		December 31, 2018
Current assets					$	10,095	$	6,517
Noncurrent assets					2,206		1,008
Current liabilities					1,116		192
Noncurrent liabilities					1,061		68